¸ßÇ帣ÀûƬ

BIOTRONIK and the University of Sydney have signed a Memorandum of Understanding to jointly develop digital and connected health solutions aimed at improving cardiac care

The collaboration brings together BIOTRONIK’s expertise in implanted cardiac devices and remote monitoring with the University’s research capabilities and the WARC: Westmead Applied Research Centre University of Sydney's experience in patient-facing digital health tools.

The initiative will focus on co-designing scalable solutions that address real-world clinical needs, particularly for patients in remote or underserved regions with limited access to care. Areas of development include remote patient monitoring, AI, and clinical decision support.

This collaboration reflects a shared commitment to advancing patient-centered, value-based healthcare through innovation and evidence-based approaches.

WARC ¸ßÇ帣ÀûƬ Spotlight: Dr Edward Yang recognised for Research Innovation

From medical researchers to neuroscientists, entrepreneurs, and leaders shaping Australia’s cultural landscape, the 2025 University of Sydney Alumni Award winners and Graduate Medallists embody leadership for good. Among them is WARC’s own Dr Edward Yang, recognised with the 2025 Medal for Innovation for his groundbreaking work developing medical technologies that improve quality of life for patients with cardiovascular disease.

It's tempting to chase perfection, but that mindset often does more harm than good. Sometimes, good enough is perfect.
— Dr Edward Yang

WARC Researchers Awarded National Honour

±Ê°ù´Ç´Ú±ð²õ²õ´Ç°ùÌýÌýand the digital health team at the Westmead Applied Research Centre have been awarded the Australian Cardiovascular Alliance Translation Award at the 2026 Australian Cardiovascular AllianceÌýExcellence in Cardiovascular Research Awards.

This achievement is a powerful example of research driving real‑world change and improving health outcomes.
— Prof Mark Scott, VC & President, University Of Sydney

The award recognises Professor Chow and the team’s outstanding leadership in translating high-quality cardiovascular research into meaningful, scalable improvements in prevention, clinical care, and population health – helping research deliver real-world impact for patients and communities.